Brief: Brainsway Receives FDA Clearance For Smoking Addiction In Adults
24/08/2020 12:47
Aug 24 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY RECEIVES FDA CLEARANCE FOR SMOKING ADDICTION IN
ADULTS
* BRAINSWAY LTD - INTENDS TO EXECUTE A CONTROLLED U.S.
MARKET
RELEASE IN EARLY 2021
* BRAINSWAY - HAS RECEIVED CLEARANCE FROM U.S. FDA FOR CO'S
DEEP
TRANSCRANIAL MAGNETIC STIMULATION SYSTEM FOR ITS USE AS AN AID
IN SHORT-TERM SMOKING CESSATION IN ADULTS
Source text for Eikon: ID:nGNX7Xk9fF
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)